1Kucher N, Goldhaber SZ. Recent advances in the diagnosis and treatment of pulmonary thromboembolism. ACC Current Journal Review, 2003, 12: 28-32.
2Bell WR, Simon TL. Current status of pulmonary thromboembolic disease: pathophy siology, diagnosis, prevention, and treatment. Am Heart J, 1982; 103: 239262.
3Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest, 2001, 119(1 Suppl): 132S-175S.
4Rosendaal FR.Venous thrombosis:The role of genes,environment,and behavior[M]// Schechter GP,Bajus JL,McArthur JR,et al.American Society of Hematology Education Program Book,Washington,DC:American Society of Hematology,2005:1-8.
5Ten Wolde M,Kraaijenhagen RA,Schiereck J,et al,Travel and the risk of symptomatic venous thromboembolism[J].Thromb Haemost,2003,89:499-505.
7Kromsdorf U,Ostermayer S,Billinger K,et al.Incidence and clinical course of thrombus formation in atrial septal defects and patent foramen ovale closure devices in 1000 consecutive patients[J].J Am Coll Cardial,2004,43:302 -309.
8Overell JR,Bone I,Lees KR,Interatrial septal abnormalities and stroke;a meta-analysis of case controlled studies[J].Neurology,2000,55:1172-1179.
9Lee AY,Rickles FR,Julian JA,et al.Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism[J].J Clin Oncol,2005,23:2123 -2129.
10Albers GW,Bates VE,Clark MN,et al.Intravenous tissue-type plasminogen activator for treatment of acute stroke the Standard Treatment with Alteplasee to Reverse Stroke (STARS) study[J].JAMA,2000,283:1145-1150.
